Wetzel Investment Advisors, Inc. Dyne Therapeutics, Inc. Transaction History
Wetzel Investment Advisors, Inc.
- $176 Million
- Q1 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 1,000 shares of DYN stock, worth $44,530. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$44,530% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
180Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$357 Million28.49% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$349 Million31.49% of portfolio
-
Black Rock Inc. New York, NY5.39MShares$240 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$203 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$189 Million0.02% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $2.31B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...